We are a phase II ready biotech company pioneering first-in-class treatments to revolutionize metabolic health. Our mission is to redefine the management of muscular wasting and diabetes, and beyond, diseases affecting millions of people globally.

By harnessing our groundbreaking technology, we aim to transform therapeutic options across a spectrum of metabolic disorders, through the development of small molecules with distinct and novel signaling profiles.